Oncology and Immuno-Oncology Precision Medicines: From Hit-Finding to Pre-Clinical Candidate Selection, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speakers will shed light on the DRIVE-SM (DRug Integrative discoVEry for Small Molecule) offering, from hit-finding to preclinical models, to assess drug pharmacology in oncology. The presenters will discuss the input of DNA encoding libraries (DEL), development of biostructural techniques and translation of pharmacological tools from in vitro to in vivo. They will also present study cases related to the characterization of specific N-α-Acetyltransferase 50 (Naa50) inhibitors identified using a DNA-encoded library, as well as use of patient-derived xenograft (PDX) cancer models.

Register for this webinar to learn about novel approaches in the discovery of new drugs in oncology, and get deeper insight into DRIVE-SM (DRug Integrative dicoVEry for Small Molecule) premium Integrated Drug Discovery Services.

This webinar will cover novel approaches in the discovery of new oncology and immuno-oncology drugs. Discovery of precision medicines requires the identification of potent and original hits with a robust validation of their mechanisms of action at the molecular level. The discovery of Naa50 binders/inhibitors using a DNA-encoded library (DEL) illustrates this challenge.

In this webinar, an expert from HitGen will talk about the application of DEL technology, including its mechanics and the advantages and challenges of the technology to those considering it for identifying ligands for their target of interest.

An expert from Oncodesign will discuss how Patient-Derived Xenograft (PDX) and PDX-derived models should be incorporated into different stages of the drug discovery process, taking example of Drug Positioning in Breast Cancer with relevant human projection.

Register for this webinar to learn about novel approaches in the discovery of new drugs in oncology, and get deeper insight into DRIVE-SM (DRug Integrative dicoVEry for Small Molecule) premium Integrated Drug Discovery Services.

Join Barry A. Morgan, Chief Scientist Officer, HitGen; and Olivier Duchamp, Head of In Vivo Sciences, Business Unit Service at Oncodesign, for the live webinar on Tuesday, May 4, 2021 at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Oncology and Immuno-Oncology Precision Medicines: From Hit-Finding to Pre-Clinical Candidate Selection.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ayesha Rashid
Xtalks
+1 (416) 977-6555 x 272
Email >
Visit website